Home
Team
Services
Transactions by Industry
Contact
BrokerCheck
Avalon
Tom Apperson 1948-2026
Jan 20

Jan 20 Tom Apperson 1948-2026

de.MO
January 2026 – Avalon Net Worth Advises on Sale of Gerson & Gerson, Inc.’s Bonnie Jean® girls’ dress business to iApparel Brands LLC
Jan 8

Jan 8 January 2026 – Avalon Net Worth Advises on Sale of Gerson & Gerson, Inc.’s Bonnie Jean® girls’ dress business to iApparel Brands LLC

de.MO

We are pleased to announce the sale of Gerson & Gerson, Inc.’s Bonnie Jean® girls’ dress business

September 2024 – Avalon Net Worth Advises on Sale of the Southpole streetwear business to to iApparel Brands, LLC.
Sep 16

Sep 16 September 2024 – Avalon Net Worth Advises on Sale of the Southpole streetwear business to to iApparel Brands, LLC.

de.MO

We are pleased to announce the sale of the Southpole business to iApparel Brands, LLC.

May 2024 – Avalon Net Worth Advises Isseks Bros., Inc. & Hall-Woodford Tank Company in connection with an investment from a multi-strategy Private Equity Group
May 28

May 28 May 2024 – Avalon Net Worth Advises Isseks Bros., Inc. & Hall-Woodford Tank Company in connection with an investment from a multi-strategy Private Equity Group

de.MO

Private Equity investors have made an investment in Isseks Bros. and its manufacturing affiliate, Hall-Woolford, Inc. 

May 2024 – Avalon Net Worth Advises on sale of Bench® trademark
May 27

May 27 May 2024 – Avalon Net Worth Advises on sale of Bench® trademark

de.MO

North & South American rights to Bench, a leading young men’s and women’s active “streetwear” brand that was founded in Manchester UK in 1989, have been …

May 2024 - $20.5 Million Mortgage Construction Loan
May 26

May 26 May 2024 - $20.5 Million Mortgage Construction Loan

de.MO

Secured a $20.5 Million First Mortgage construction loan for a Build to Rent Owner/Operator to support the development and stabilization of its “Build to Rent” Community in the Sunbelt.

December 2023 - NanoRustX Established a Joint Venture with Shandong Zibo First Line Group
Dec 28

Dec 28 December 2023 - NanoRustX Established a Joint Venture with Shandong Zibo First Line Group

de.MO

December 2023 - Avalon acted as the Transaction Advisor to NanoRustX, a developer of a revolutionary anti-corrosion primer coating technology, in the negotiations…

December 2023 - Green Dot Bioplastics Feature in PBS Documentary Series, My World Too
Dec 1

Dec 1 December 2023 - Green Dot Bioplastics Feature in PBS Documentary Series, My World Too

de.MO

December 2023 - Avalon’s client, Green Dot Bioplastic, will be part of PBS’s documentary series My World Too! The series is current in its 3rd season and it is their…

October 2023 – Avalon Net Worth Advises Almost Famous in its sale to Steve Madden, Ltd.
Oct 25

Oct 25 October 2023 – Avalon Net Worth Advises Almost Famous in its sale to Steve Madden, Ltd.

de.MO

We are pleased to share news of the acquisition of our client, Almost Famous, a $163 million designer and marketer of women’s apparel, by Steve Madden, Ltd…

August 2023 – Vocxi Health and S3 Connected Health Partner to Transform Lung Cancer Screening and Monitoring
Aug 25

Aug 25 August 2023 – Vocxi Health and S3 Connected Health Partner to Transform Lung Cancer Screening and Monitoring

de.MO

Congratulations to Avalon Securities client Vocxi Health, a breath diagnostics company, for partnering with S3 Connected Health…

August 2023 – SmartLabs Sets Roadmap for the Future of Science with New, End-to-End R&D Support
Aug 25

Aug 25 August 2023 – SmartLabs Sets Roadmap for the Future of Science with New, End-to-End R&D Support

de.MO

Avalon’s Series A Client, SmartLabs, has announced their total support capabilities for end-to-end R&D processes through the offering…

June 2023 – Avalon Securities Arranges $35 Million Working Capital Facility for Newly Formed Entity Bringing Jobs from Asia to the United States.
Jun 30

Jun 30 June 2023 – Avalon Securities Arranges $35 Million Working Capital Facility for Newly Formed Entity Bringing Jobs from Asia to the United States.

de.MO

Avalon Securities Ltd. is pleased to announce the closing of a non-dilutive, $35 million working capital facility…

March 2023 – Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications | Hovione
Mar 23

Mar 23 March 2023 – Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications | Hovione

de.MO

Avalon’s client, Laxxon Medical has formed an agreement with Hovione regarding cGMP production of 3D…

March 2023 – SmartLabs Announces Launch of its Most Advanced Managed Research Center
Mar 2

Mar 2 March 2023 – SmartLabs Announces Launch of its Most Advanced Managed Research Center

de.MO

Avalon’s client, SmartLabs, has announced plans to expand high-performance laboratory facilities in Philadelphia…

March 2023 - Avalon Net Worth Advises Milrose Consultants & Southfield Capital in Transaction with Howard L. Zimmerman Architects & Engineers
Mar 1

Mar 1 March 2023 - Avalon Net Worth Advises Milrose Consultants & Southfield Capital in Transaction with Howard L. Zimmerman Architects & Engineers

de.MO

March 2023 - Avalon Net Worth Advises Milrose Consultants & Southfield Capital in Transaction with Howard L. Zimmerman…

August 2022 – SmartLabs Announces Plans to Expand High-Performance Laboratory Facilities in Philadelphia
Aug 1

Aug 1 August 2022 – SmartLabs Announces Plans to Expand High-Performance Laboratory Facilities in Philadelphia

de.MO

Avalon’s client, SmartLabs, has announced plans to expand high-performance laboratory facilities in Philadelphia…

July 2022 - Green Dot Bioplastics Launches 9 New Compostable Resins for Expanded Single-Use and Industrial Applications
Jul 31

Jul 31 July 2022 - Green Dot Bioplastics Launches 9 New Compostable Resins for Expanded Single-Use and Industrial Applications

de.MO

July 2022 - Avalon’s client, Green Dot Bioplastic, has announced that they are expanding their product offering for Packaging and Single-Use Disposable applications…

Q2 2022 - $25MM for an Alternative Credit Fund
May 12

May 12 Q2 2022 - $25MM for an Alternative Credit Fund

de.MO

Arranged $25MM fund leverage facility for a long track record Credit Fund client arranged…

Q1 2022 - $150MM for a Litigation Finance Lender
Jan 13

Jan 13 Q1 2022 - $150MM for a Litigation Finance Lender

de.MO

Arranged $150MM credit facility for an institutional caliber litigation finance lender which…

Q4 2021 - $300MM for an Institutional Credit Manager
Dec 31

Dec 31 Q4 2021 - $300MM for an Institutional Credit Manager

de.MO

Arranged $300MM tranche of an asset management assignment for a client that is an…

Load More

Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Avalon Securities Ltd is not a registered broker-dealer, and Finalis Securities LLC and Avalon Securities Ltd are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.

Finalis Privacy Policy | Finalis Business Continuity Plan | Finalis Form Customer Relationship Summary (“Form CRS”)

www.AvalonSecuritiesLtd.com (the "Avalon Website") is a website operated by Avalon Securities Ltd. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities LLC registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Avalon Securities Ltd along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.

Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC. 

Disclaimers, Terms and Conditions of Use and Privacy Policy Statement FINRA BrokerCheck©
©Copyright 2026 Avalon Securities Ltd. All rights reserved.

News